Information updates

Allergic rhinitis (hay fever) treatment update

November 30, 2017: 

New Clinical Guidelines from the US on allergic rhinitis (hay fever) treatment were published this week (28 November 2017) in the Annals of Internal Medicine

The Guidelines were developed by representatives of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI).  Their recommendations for initial treatment of seasonal allergic rhinitis emphasise the use of an intranasal corticosteroid rather than an intranasal corticosteroid in combination with an oral antihistamine.

The Australasian Society of Clinical Immunology and Allergy (ASCIA) website includes the following information for patients, consumers and carers about allergic rhinitis medication options:

In addition, the ASCIA allergic rhinitis clinical update for health professionals includes the following key points:

For further information from the ASCIA website go to: - e-training for pharmacists accredited by the APC - e-training for other health professionals


For recent media reports on this topic go to: the radio interview with the ASCIA President Dr William Smith starts at 1:42:50 and ends at 1:54:30 (expired) (expired)

July 2020